New York City officials have confirmed the first case of a more severe strain case of mpox. While the risk of transmission remains low, shares of certain vaccine-makers might be worth a second look.

Osmundson is a clinical assistant professor of biology at New York University and author of “Virology.” Paredes is an infectious disease epidemiologist at the University of Washington. As queer ...

The FDA-approved non-replicating mpox vaccine Jynneos® requires two doses and provides a relatively short duration of protection. FDA also recently approved ACAM2000, a live, replicating vaccinia ...